| | N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide|GSK1120212 中间体 9 基本信息 更多信息 |
| 中文名称: | GSK1120212 中间体 9 | | 中文同义词: | GSK1120212 中间体 9;N-[3-[[3-环丙基-1-(2-氟-4-碘苯基)-6,8-二甲基-2,4,7-三氧代-1,2,3,4,7,8-六氢吡啶并[2,3-D]嘧啶-5-基]氨基]苯基]乙酰胺;N-[3-[[3-环丙基-1-(2-氟-4-碘苯基)-1,2,3,4,7,8-六氢-6,8-二甲基-2,4,7-三氧代吡啶并[2,3-D]嘧啶-5-基]氨基]苯基]乙酰胺;曲美替尼杂质1;曲美替尼杂质2;曲美替尼杂质6 | | 英文名称: | N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide | | 英文同义词: | N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide;N-(3-(3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydrop;Trametinib Impurity 1;Acetamide, N-[3-[[3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-1,2,3,4,7,8-hexahydro-6,8-dimethyl-2,4,7-trioxopyrido[2,3-d]pyrimidin-5-yl]amino]phenyl]-;Trametinib Impurity 2;Trametinib Impurity 6;Olaquindox Impurity 9 | | CAS号: | 871700-25-3 | | 分子式: | C26H23FIN5O4 | | 分子量: | 615.39 | | EINECS号: | | ![N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide|GSK1120212 中间体 9](/CAS/GIF/871700-25-3.gif) |
|
| 按国家浏览N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide国外供应商 |
中国供应商 |
|
N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide 推荐供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
1
|